Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors
Molibresib (GSK525762)(一种溴结构域和末端结构域蛋白抑制剂)治疗 NUT 癌和其他实体瘤的 1 期研究
期刊:JNCI Cancer Spectrum
影响因子:4.1
doi:10.1093/jncics/pkz093
Piha-Paul, Sarina A; Hann, Christine L; French, Christopher A; Cousin, Sophie; Braña, Irene; Cassier, Phillippe A; Moreno, Victor; de Bono, Johann S; Harward, Sara Duckworth; Ferron-Brady, Geraldine; Barbash, Olena; Wyce, Anastasia; Wu, Yuehui; Horner, Thierry; Annan, Meg; Parr, Nigel J; Prinjha, Rabinder K; Carpenter, Christopher L; Hilton, John; Hong, David S; Haas, Naomi B; Markowski, Mark C; Dhar, Arindam; O'Dwyer, Peter J; Shapiro, Geoffrey I